Download Citation
Article Source:
Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models
Marcus P,
Warrington J,
Zhang M,
Ankathatti-Munegowda M,
Wang XH,
et al.
(2026)
Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.
PLOS ONE 21(4): e0347095.
https://doi.org/10.1371/journal.pone.0347095